levofloxacin has been researched along with Infection, Wound in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, E; Kanta, S; Kumari, S; Rahi, DK; Razdan, K; Sinha, VR; Yadav, AK | 1 |
| Amani, A; Farahmandfar, M; Pourmand, MR; Sereshti, H; Shirzad, M; Valizadeh, A | 1 |
| Abdelaziz, AA; El-Barrawy, MA; El-Nagar, RAM | 1 |
| Hadano, Y; Ohkusu, K; Tamagawa, K | 1 |
| Combs, N; Elliott, K; Kalaria, SS; Phillips, LG | 1 |
| Jia, XQ; Li, YH; Pang, F; Wang, B; Zhao, QG | 1 |
| Bolduc, DL; Elliott, TB; Fatanmi, OO; Kiang, JG; Ledney, GD; Newman, VL; Romaine, PL; Singh, VK; Wise, SY | 1 |
| Bonavila Juan, C; Goenaga Sánchez, MÁ; Michelena Bengoechea, A; Zubeltzu Sese, B | 1 |
| Daschner, F; Schmidt-Eisenlohr, E; Wenzler, S | 1 |
| Al-Lahham, A; Lütticken, R; Reinert, RR | 1 |
| Benzonana, NA; Ozer, S; Oznur, AK | 1 |
| Chang, CY; Lee, YT; Liu, KS; Tsao, SM; Wang, YL | 1 |
| Citron, DM; Goldstein, EJ; Nesbit, CA | 1 |
| Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 2 |
1 review(s) available for levofloxacin and Infection, Wound
| Article | Year |
|---|---|
[Recurrent endocarditis due to Brevibacterium casei: case presentation and a review of the literature].
Topics: Actinomycetales Infections; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Brevibacterium; Ceftriaxone; Disease Susceptibility; Drug Therapy, Combination; Emergencies; Endocarditis, Bacterial; Facial Dermatoses; Gentamicins; Humans; Levofloxacin; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Recurrence; Tetracycline; Vancomycin; Wound Infection | 2017 |
14 other study(ies) available for levofloxacin and Infection, Wound
| Article | Year |
|---|---|
Levofloxacin loaded clove oil nanoscale emulgel promotes wound healing in Pseudomonas aeruginosa biofilm infected burn wound in mice.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Burns; Clove Oil; Levofloxacin; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Wound Healing; Wound Infection | 2023 |
Levofloxacin nanoemulsion gel has a powerful healing effect on infected wound in streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Levofloxacin; Rats; Rats, Wistar; Skin; Streptozocin; Wound Infection | 2021 |
Potent synergistic combination of rosuvastatin and levofloxacin against Staphylococcus aureus: in vitro and in vivo study.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Biofilms; Coagulase; Disease Models, Animal; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Hemolysin Proteins; Levofloxacin; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rosuvastatin Calcium; Sphingomyelin Phosphodiesterase; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors; Wound Infection | 2021 |
Trauma Wound Related Infection Caused by Enterobacter cancerogenus and Aeromonas hydrophilia.
Topics: Aeromonas hydrophila; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Enterobacter; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Meropenem; Thienamycins; Treatment Outcome; Wound Infection | 2018 |
Raoultella planticola: A Rare Cause of Wound Infection.
Topics: Aged; Anti-Bacterial Agents; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Wound Infection | 2017 |
Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases.
Topics: Adolescent; Anti-Bacterial Agents; Arthritis, Infectious; beta-Lactam Resistance; beta-Lactamases; China; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Fracture Fixation, Internal; Humans; Infection Control; Klebsiella Infections; Klebsiella oxytoca; Levofloxacin; Male; Meropenem; Middle Aged; Osteitis; Patient Isolation; Protective Clothing; Retrospective Studies; Surgical Wound Infection; Thienamycins; Universal Precautions; Wound Infection | 2014 |
Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Bacterial Infections; Chemokines; Cord Factors; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Gamma Rays; Growth Substances; Immunologic Factors; Levofloxacin; Lipid A; Mice; Radiation Injuries, Experimental; Sepsis; Skin; Wound Infection | 2015 |
Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections.
Topics: Abdominal Injuries; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria, Aerobic; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Respiratory Tract Infections; Wound Infection | 2004 |
High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
Topics: Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Germany; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; Polymerase Chain Reaction; Population Surveillance; Streptococcal Infections; Streptococcus pyogenes; Wound Infection | 2004 |
[Antibiotic resistance in Streptococcus pneumoniae strains isolated from sterile body sites].
Topics: Anti-Bacterial Agents; Bacteremia; Cerebrospinal Fluid; Dacryocystitis; Drug Resistance, Bacterial; Ear, Middle; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Pleural Effusion; Pneumococcal Infections; Streptococcus pneumoniae; Synovial Fluid; Wound Infection | 2006 |
Chromobacterium violaceum infection in Taiwan: a case report and literature review.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chromobacterium; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Taiwan; Wound Infection | 2007 |
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Wound Infection | 1995 |
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.
Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Cats; Ciprofloxacin; Dogs; Fluoroquinolones; Haplorhini; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Swine; Wound Infection | 1997 |
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bites and Stings; Bites, Human; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Species Specificity; Wound Infection | 1998 |